Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model-Reference-Cited by-同舟云学术

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model

Published:2019-05-27 Issue:8 Volume:8 Page:1593804
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zoine Jaquelyn T.¹²,Knight Kristopher A.¹,Fleischer Lauren C.¹³,Sutton Kathryn S.¹⁴,Goldsmith Kelly C.¹⁴,Doering Christopher B.¹,Spencer H. Trent¹

Affiliation:

1. Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

2. Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA, USA

3. Molecular and Systems Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, GA, USA

4. Children’s Healthcare of Atlanta, Atlanta, GA, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2019.1593804

Reference61 articles.

1. Neuroblastoma

2. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

3. Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study

4. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15

2. Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells;Frontiers in Immunology;2024-02-29

3. Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells;Nature Communications;2023-12-20

4. Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia;Frontiers in Immunology;2023-11-13

5. The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1;OncoImmunology;2023-08-05